ロード中...
Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy
More than 10 clinical trials of Aβ immunotherapy are currently underway in patients with Alzheimer’s disease (AD). The aim is to identify safe approaches for the efficacious antibody-mediated removal of brain β-amyloid or its neurotoxic oligomeric precursors consisting of aggregated amyloid β-peptid...
保存先:
| 出版年: | Neurotherapeutics |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084243/ https://ncbi.nlm.nih.gov/pubmed/18625453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|